[
    [
        {
            "time": "2019-12-23",
            "original_text": "【太平洋医药】第二轮全国集采方案公布，继续推荐景气度好，行业天花板高，不受政策影响/影响较小的细分领域",
            "features": {
                "keywords": [
                    "全国集采",
                    "景气度",
                    "政策影响",
                    "细分领域"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【太平洋医药】第二轮全国集采方案公布，继续推荐景气度好，行业天花板高，不受政策影响/影响较小的细分领域",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-23",
            "original_text": "梳理与展望，盘点2019的“热点”与“冷门” -- 医药行业周报（2019.12.23-2019.12.29）",
            "features": {
                "keywords": [
                    "热点",
                    "冷门",
                    "医药行业周报"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "梳理与展望，盘点2019的“热点”与“冷门” -- 医药行业周报（2019.12.23-2019.12.29）",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2020-01-01",
            "original_text": "中信建投策略首席分析师张玉龙：2020年“牛蹄”稍慢 两类股有机会",
            "features": {
                "keywords": [
                    "中信建投",
                    "张玉龙",
                    "牛蹄",
                    "机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中信建投策略首席分析师张玉龙：2020年“牛蹄”稍慢 两类股有机会",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "来看看2019年资本市场十大风云董事长都有谁",
            "features": {
                "keywords": [
                    "资本市场",
                    "风云董事长"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "来看看2019年资本市场十大风云董事长都有谁",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "第二批药品集中采购启动！涉及100多家药企，这份上市公司名单含金量最高",
            "features": {
                "keywords": [
                    "药品集中采购",
                    "药企",
                    "上市公司名单"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "第二批药品集中采购启动！涉及100多家药企，这份上市公司名单含金量最高",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "3股获买入评级 最新:恒瑞医药",
            "features": {
                "keywords": [
                    "买入评级",
                    "恒瑞医药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "3股获买入评级 最新:恒瑞医药",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "机构称科技主题将引领A股走出结构性牛市",
            "features": {
                "keywords": [
                    "科技主题",
                    "A股",
                    "结构性牛市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "机构称科技主题将引领A股走出结构性牛市",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "百济神州正式入局 国内PD-1单抗“4＋2”竞争局面形成",
            "features": {
                "keywords": [
                    "百济神州",
                    "PD-1单抗",
                    "竞争局面"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "百济神州正式入局 国内PD-1单抗“4＋2”竞争局面形成",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "【国盛医药张金洋团队】周观点：肝素到底是周期还是成长？——兼论全球肝素产业链重构",
            "features": {
                "keywords": [
                    "肝素",
                    "周期",
                    "成长",
                    "产业链重构"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国盛医药张金洋团队】周观点：肝素到底是周期还是成长？——兼论全球肝素产业链重构",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "百元股成群结队来了！昔日“股王”半数股价腰斩，10只仅剩零头，最牛股飙涨超100倍",
            "features": {
                "keywords": [
                    "百元股",
                    "股王",
                    "股价腰斩"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "百元股成群结队来了！昔日“股王”半数股价腰斩，10只仅剩零头，最牛股飙涨超100倍",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "第二轮全国带量采购方案出台，中选企业数进一步增加",
            "features": {
                "keywords": [
                    "带量采购",
                    "中选企业数"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "第二轮全国带量采购方案出台，中选企业数进一步增加",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "【国信医药】新一轮国家药品集采文件公布，涉及33个新品种（行业重大事件快评）",
            "features": {
                "keywords": [
                    "国家药品集采",
                    "新品种"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国信医药】新一轮国家药品集采文件公布，涉及33个新品种（行业重大事件快评）",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-28",
            "original_text": "A股科技龙头50强出炉！拿下A股6%市值，三年飞出3只十倍股",
            "features": {
                "keywords": [
                    "A股科技龙头",
                    "市值",
                    "十倍股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股科技龙头50强出炉！拿下A股6%市值，三年飞出3只十倍股",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]